Back to top
more

Assertio (ASRT)

(Delayed Data from NSDQ)

$1.54 USD

1.54
1,655,415

-0.12 (-7.23%)

Updated Jul 15, 2024 04:00 PM ET

After-Market: $1.55 +0.01 (0.65%) 5:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (157 out of 250)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

Sarepta (SRPT) Q4 Earnings Beat, DMD Drugs Sales Robust

Strong demand for Sarepta's (SRPT) DMD drugs boosts its top line in the fourth quarter. The company also raises revenue guidance for the year. Stock down in after-market trading.

JAZZ Q4 Earnings Top, Sales Ride on New & Acquired Drugs

JAZZ's product revenues grow in the fourth quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals.

Kinjel Shah headshot

4 Small Drug Stocks That Appear to Be Solid Bets in a Challenging Industry

Some business disruption due to COVID-19 was felt by the Medical-Drugs industry players in 2021. CPRX, KDNY, ASRT and SGTX may prove to be good additions to one's portfolio.

Perrigo (PRGO) Q4 Earnings Beat as Cough & Cold Sales Recover

Perrigo (PRGO) reports encouraging fourth-quarter 2021 results. Sales of cough/cold products continue the strong rebound during the reported quarter. Stock gains.

Assertio (ASRT) Shows Fast-paced Momentum But Is Still a Bargain Stock

Assertio (ASRT) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Here is how Assertio (ASRT) and Homology Medicines (FIXX) have performed compared to their sector so far this year.

MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 31.58% and 139.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Has Assertio (ASRT) Outpaced Other Medical Stocks This Year?

Here is how Assertio (ASRT) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.

Despite Fast-paced Momentum, Assertio (ASRT) Is Still a Bargain Stock

Assertio (ASRT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Is Accuray (ARAY) Outperforming Other Medical Stocks This Year?

Here is how Accuray (ARAY) and Assertio (ASRT) have performed compared to their sector so far this year.

Do Options Traders Know Something About Assertio (ASRT) Stock We Don't?

Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately.

ImmunoGen (IMGN) Surges on Successful Ovarian Cancer Study

ImmunoGen (IMGN) reports successful completion of a pivotal study evaluating its lead pipeline candidate as monotherapy in certain ovarian cancer patients previously treated with Avastin.

Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval

The FDA grants approval to the new drug application seeking approval for Takeda's (TAK) maribavir for treating post-transplant cytomegalovirus infection.

Assertio (ASRT) Shows Fast-paced Momentum But Is Still a Bargain Stock

Assertio (ASRT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of 300.00% and 15.57%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Assertio (ASRT) Q3 Earnings Expected to Decline

Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for September 9th

ASRT, CVGW, NTRB, ITRG, and KNBWY have been added to the Zacks Rank #5 (Strong Sell) List on September 9, 2021

New Strong Sell Stocks for September 7th

ASRT, GLDD, MOGO, XPO, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on September 7, 2021

Assertio (ASRT) Reports Q2 Loss, Tops Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of -300.00% and 24.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Assertio (ASRT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aditi Saraogi headshot

Implied Volatility Surging for Assertio Holdings (ASRT) Stock Options

Investors need to pay close attention to for Assertio Holdings (ASRT) stock based on the movements in the options market lately.

Implied Volatility Surging for Assertio Holdings (ASRT) Stock Options

Investors need to pay close attention to Assertio Holdings (ASRT) stock based on the movements in the options market lately.

Assertio (ASRT) Reports Next Week: What to Expect

Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Do Options Traders Know Something About Assertio (ASRT) Stock We Don't?

Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Assertio Holdings (ASRT) Stock?

Investors need to pay close attention to Assertio Holdings (ASRT) stock based on the movements in the options market lately.